Systematic review and meta-analysis of genomic alterations in acral melanoma.
Natasa BroitPeter A JohanssonChloe B RodgersSebastian T WalpoleNicholas K HaywardAntonia L PritchardPublished in: Pigment cell & melanoma research (2022)
Acral melanoma (AM) tumors arise on the palms, soles, fingers, toes, and nailbeds. A comprehensive systematic meta-analysis of AM genomic aberrations has not been conducted to date. A literature review was carried out to identify studies sequencing AM. Whole-genome/exome data from 181 samples were identified. Targeted panel sequencing data from MSK-IMPACT were included as a validation cohort (n = 92), and studies using targeted hot spot sequencing were also collated for BRAF (n = 26 studies), NRAS (n = 21), and KIT (n = 32). Statistical analysis indicated BRAF, NRAS, PTEN, TYRP1, and KIT as significantly mutated genes. Frequent copy-number aberrations were also found for important cancer genes, such as CDKN2A, KIT, MDM2, CCND1, CDK4, and PAK1, among others. Mapping genomic alterations within the context of the hallmarks of cancer identified four components frequently altered, including (i) sustained proliferative signaling and (ii) evading growth suppression, (iii) genome instability and mutation, and (iv) enabling replicative immortality. This analysis provides the largest analysis of genomic aberrations in AM in the literature to date and highlights pathways that may be therapeutically targetable.
Keyphrases
- copy number
- genome wide
- mitochondrial dna
- wild type
- dna methylation
- papillary thyroid
- single cell
- case control
- systematic review
- electronic health record
- squamous cell
- big data
- cancer therapy
- high resolution
- metastatic colorectal cancer
- cell proliferation
- squamous cell carcinoma
- case report
- machine learning
- skin cancer
- cell cycle
- lymph node metastasis
- young adults
- transcription factor
- mass spectrometry
- bioinformatics analysis
- drug delivery
- genome wide identification
- genome wide analysis